The present Competitive Intelligence report about IGF-1/R Antagonists provides a competitor evaluation in the field of novel molecular entities directed against the insulin-like growth factor-1 receptor (IGF-1R) or its ligands IGF-1 and IGF-2 for treatment of cancer as of June 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Access data will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of IGF-1/R Antagonists in oncology. In addition, the report lists company-specific R&D pipelines of IGF-1/R antagonists. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Product Category,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.